Telomir Pharmaceuticals, Inc. Common Stock (TELO) NASDAQ

1.27

-0.04(-3.05%)

Updated at February 27 04:00PM

Currency In USD

Valuation

Market Cap121.7M
Enterprise Value120.53M
P/E Ratio-3.5
PEG Ratio-0.12
Price/Sales Ratio0
Price/Book Ratio5.65
Enterprise/Revenue0
Enterprise/EBITDA-3.24

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-1.52
Return On Equity-5.67

Income Statement

Revenue0
Revenue/Share0
Gross Profit0
EBITDA48,000
Net Income-16.53M
Diluted EPS-0.56

Balance Sheet

Total Cash7.33M
Total Cash/Share0.24
Total Debt93,432
Total Debt/Equity0.01
Current Ratio17.51
Book Value Per Share0.22

Price History

52-Week Change-67.52
52-Week High5.4
52-Week Low1.05
Moving Average 50 Days1.29
Moving Average 200 Days1.53

Statistics

Average Volume182,490
Shares Outstanding34.38M
% Held by Institutions7.32

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A